Study on the Reapplication of Chloraprep After Lower Extremity Surgery and Prior to Dressing Application
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02017145|
Recruitment Status : Unknown
Verified February 2014 by Kyle Judd, Sanford Health.
Recruitment status was: Recruiting
First Posted : December 20, 2013
Last Update Posted : February 19, 2014
|Condition or disease||Intervention/treatment||Phase|
|Lower Extremity Surgery Surgical Site Infection Bacterial Colonization Surgical Antiseptic||Drug: Chloraprep||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||140 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Participant, Outcomes Assessor)|
|Official Title:||Role of Post-operative Re-application of Chloraprep® Following Lower Extremity Surgeries on Surgical Site Bacterial Colonization.|
|Study Start Date :||February 2014|
|Estimated Primary Completion Date :||February 2015|
No Intervention: no reapplication
This group will not have chloraprep reapplied after their surgery and prior to dressing application.
This group will have chloraprep reapplied following their lower extremity surgical procedure and prior to dressing application.
- quantitative bacterial colonization [ Time Frame: 14-21 days ]Compare the number of colony forming units taken from culture swabs immediately adjacent to the wound during dressing change between the two arms
- positive culture rate [ Time Frame: 14-21 days ]Compare the overall positive culture rate between the two treatment groups
- bacterial strain identification [ Time Frame: 14-21 days ]Assess the total number of bacterial strains and identifying those strains cultured from swabs taken immediately adjacent to the wound during dressing change
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02017145
|Contact: Jeremy P Morgan, MSfirstname.lastname@example.org|
|Contact: Diane Hahnemail@example.com|
|United States, South Dakota|
|Sanford USD Medical Center||Recruiting|
|Sioux Falls, South Dakota, United States, 57117|
|Contact: Kyle T Judd, MD 605-328-2663 firstname.lastname@example.org|
|Principal Investigator: Kyle T Judd, MD|
|Principal Investigator:||Kyle T Judd, MD||Sanford Orthopedics and Sports Medicine|